Viagra for the Ladies?
Did you know that there's a condition called "hypoactive sexual desire disorder," from which many women suffer? Well, there is, or at least a bunch of scientists have decided there is, and sadly, about 10 percent of premenopausal women grapple with it. Luckily, if unsurprisingly, there might be a pill in the works for just this issue.
Did you know that there’s a condition called “hypoactive sexual desire disorder,” from which many women suffer? Well, there is, or at least a bunch of scientists have decided there is, and sadly, about 10 percent of premenopausal women grapple with it. Luckily, if unsurprisingly, there might be a pill in the works for just this issue. –KA
WAIT BEFORE YOU GO...Nizagara-online.net via Gawker:
“We have to give women some type of option,’’ said Beverly Whipple, a professor emeritus at Rutgers University and an expert on women’s sexual health. “I’m hoping this will help the women who need it.’’
One expert, Andrew Goldstein who runs the Sexual Wellness Center in Annapolis, Md., described a “huge’’ unmet need for a medical treatment.
Women who took the medicine, known as flibanserin, reported 22 percent more “satisfying sexual events” than those given a placebo in two clinical tests of 1,378 patients, according to abstracts released today at the European Society for Sexual Medicine annual meeting in Lyon, France.
This year, the ground feels uncertain — facts are buried and those in power are working to keep them hidden. Now more than ever, independent journalism must go beneath the surface.
At Truthdig, we don’t just report what's happening — we investigate how and why. We follow the threads others leave behind and uncover the forces shaping our future.
Your tax-deductible donation fuels journalism that asks harder questions and digs where others won’t.
Don’t settle for surface-level coverage.
Unearth what matters. Help dig deeper.
Donate now.
Book Excerpt
Seventy-five years ago in Chicago, a conservative project was hatched to cure classical economics of its aversion to patents and monopolies. The drug companies were its first and biggest beneficiaries.
Business & Economy
The pharmaceutical giant refuses to make its vaccine technology available to all.
The opioid-pushing pharmaceutical companies may finally be forced to pay some of their billions to help remediate the crisis they helped manufacture. The state of Oklahoma won a big court victory against Johnson & Johnson, the huge corporation that downplayed the risks of opioids while keeping the country awash in their deadly product. Johnson & Johnson and […]
The presidential candidate travels with a caravan of type 1 diabetes patients seeking affordable insulin in America's northern neighbor.
The president is now focusing his drive to curb drug costs on congressional efforts.
You need to be a supporter to comment.
There are currently no responses to this article.
Be the first to respond.